BAC

Bank of America Corporation

60
Fundamentals72/ 100
Valuation55/ 100
Upside potential71/ 100
Risk potential10/ 100

BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.

MKLY

McKinley Acquisition Corporation Class A Ordinary Shares

There isn't enough reported data to score MKLY yet.

BAC Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.

MKLY Fundamentals

MetricStatus
Unavailable
Healthy
N/A
N/A

MKLY's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like MKLY.

BAC PE Valuation

CHEAPFAIREXPENSIVE5.6x11x17x22x
CHEAPFAIREXPENSIVE5.6x11x17x22x
LevelPEPriceVs current
Cheap9.4x$39.50-22%
Forward10x$50.51—
Current12x$50.51—
Fair13x$53.81+6.5%
Expensive15x$62.23+23%

Historical ranges are pointers, not guarantees.

BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.

MKLY PE Valuation

CHEAPFAIREXPENSIVE16x32x48x65x
CHEAPFAIREXPENSIVE16x32x48x65x
LevelPEPriceVs current
Current45x$10.30—
Cheap50x$11.46+11%
Fair62x$14.15+37%
Expensive62x$14.24+38%

Historical ranges are pointers, not guarantees.

MKLY has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.

BAC Forward outlook

MetricOutlook
Improving
Growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for BAC, with profitability improving.

MKLY Forward outlook

There aren't enough analyst estimates for MKLY to show an outlook.

BAC Risk to reward

ScenarioChangePrice
Upside+25%$63.36
Downside-10%$45.36

Calculated from the latest close: $50.51 on Nov 12.

There is not enough scenario data to compare BAC and MKLY's risk to reward.

MKLY Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.30 on Nov 12.

There is not enough scenario data to compare BAC and MKLY's risk to reward.

BAC Earnings Per Share

Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
QuarterTTM EPSYoY
Forward$4.92+17%
Q3 2026$4.19+14%
Q2 2026$4.34+27%
Q1 2026$4.02+20%
Q4 2025$3.81+19%
Q3 2025$3.66+33%
Q2 2025$3.41+20%
Q1 2025$3.35+16%
Q4 2024$3.21+4.2%

BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.

MKLY Earnings Per Share

Q1 2026: $0.17Q2 2026: $0.23
Q1 2026: $0.17Q2 2026: $0.23

MKLY and BAC do not have enough comparable growth data to identify a winner.

BAC Quarterly Revenue

Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
QuarterRevenueYoY
Q3 2026$30B+6.7%
Q2 2026$31.6B+19%
Q1 2026$30.3B+11%
Q4 2025$31.2B+23%
Q3 2025$28.1B+11%
Q2 2025$26.5B+4.3%
Q1 2025$27.4B+6%
Q4 2024$25.3B+15%

BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.

MKLY Quarterly Revenue

Q1 2025: --Q2 2025: --Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q1 2025: --Q2 2025: --Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0

MKLY and BAC do not have enough comparable growth data to identify a winner.

BAC Free Cash Flow

Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
QuarterFree cash flowYoY
Q3 2026-$6.5B-114%
Q2 2026$29B+$38.2B
Q1 2026$41.8B+$44B
Q4 2025-$22.9B-189%
Q3 2025$46.9B+$84.2B
Q2 2025-$9.1B-150%
Q1 2025-$2.2B+$13.4B
Q4 2024$25.9B-21%

BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.

MKLY Free Cash Flow

Q1 2025: --Q2 2025: −$111,509Q3 2025: −$286,605Q4 2025: −$250,831Q1 2026: −$253,028Q2 2026: −$382,426
Q1 2025: --Q2 2025: −$111,509Q3 2025: −$286,605Q4 2025: −$250,831Q1 2026: −$253,028Q2 2026: −$382,426
QuarterFree cash flowYoY
Q2 2026-$382.4K-$270.9K

MKLY and BAC do not have enough comparable growth data to identify a winner.

BAC Total Shares

Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
PeriodChange %Net change
Quarterly-1%-72M shares
1 year-5.3%-405M shares
3 years-11%-854M shares
5 years-15%-1.3B shares
Available history-24%-2.2B shares

BAC has the edge over MKLY on shareholder dilution, with a more favorable share count trend.

MKLY Total Shares

Q2 2025: 6MQ3 2025: 16MQ4 2025: 24MQ1 2026: 17MQ2 2026: 17M
Q2 2025: 6MQ3 2025: 16MQ4 2025: 24MQ1 2026: 17MQ2 2026: 17M
PeriodChange %Net change
Quarterly0%--
1 year+203%+11.6M shares

MKLY has 17M diluted shares, up 203% from a year ago.

BAC Net Leverage

Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
QuarterNet LeverageStatus
Q3 20266.4xHigh
Q2 20266.7xHigh
Q1 20267.1xHigh
Q4 20257.7xHigh
Q3 20258.3xHigh
Q2 20258.8xHigh
Q1 20258.6xHigh
Q4 20249.0xHigh

BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.

MKLY Net Leverage

BAC Weekly Momentum

MetricValueStatus
RSI37.1Neutral
Stochastic4.9Oversold

BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).

MKLY Weekly Momentum

MetricValueStatus
RSI74.9Overbought
Stochastic84.1Overbought

MKLY's weekly RSI is 75 (overbought) and its Stochastic is 84 (overbought).

BAC PE vs Financial Services Sector

MetricBACSector medianRelative
PE12x13x7.5% below
PE %406323 pts below

BAC has the edge over MKLY on valuation relative to its sector.

MKLY PE vs Financial Services Sector

MetricMKLYSector medianRelative
PE45x13x247% above
PE %15105 pts above

MKLY is trading at 45x earnings, a 247% premium to the Financial Services sector's median of 13x, though its earnings don't support one.

BAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$52.13% below
20 week MA$57.813% below
50 week MA$54.77.7% below
100 week MA$50.50% below
200 week MA$42.519% above

MKLY has stronger trend alignment. BAC is above 1 of 5 weekly averages versus MKLY above 3 of 3.

MKLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.30.2% above
20 week MA$10.20.6% above
50 week MA$10.11.7% above

MKLY is in an uptrend: it's above all three of its weekly moving averages, and 1.7% above its 50-week average.

BAC Yearly ROI

YearStart priceEnd priceROI
2020$35.4$30.0-15%
2021$30.0$44.4+48%
2022$44.4$32.5-27%
2023$32.5$33.7+3.7%
2024$33.7$44.3+32%
2025$44.3$56.2+27%
2026 YTD$56.2$50.5-10%

BAC has finished higher in four of the last six years. It's down 10% so far in 2026.

MKLY Yearly ROI

YearStart priceEnd priceROI
2025$9.89$9.98+0.9%
2026 YTD$9.98$10.3+3.2%

MKLY has the edge over BAC on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key